Exhibit 21.1

Subsidiaries

Name of Subsidiary	Jurisdiction of Incorporation or Organization	Percentage of Ownership by the Registrant
BeiGene 101	Cayman Islands		100	%
BeiGene Argentina S.R.L.	Argentina		100	%
BeiGene AUS Pty Ltd	Australia		100	%
BeiGene Austria GmbH	Austria		100	%
BeiGene (Beijing) Co., Ltd.	People’s Republic of China		100	%
BeiGene Belgium SRL	Belgium		100	%
BeiGene Biologics Co., Ltd.	People’s Republic of China		100	%
BeiGene Brasil Ltda.	Brazil		100	%
BeiGene (Canada) ULC	Canada		100	%
BeiGene Chile Limitada	Chile		100	%
BeiGene Colombia S.A.S.	Colombia		100	%
BeiGene ESP, S.L.U. Unipersonal	Spain		100	%
BeiGene France Sarl	France		100	%
BeiGene Germany GmbH	Germany		100	%
BeiGene Guangzhou Biologics Manufacturing Co., Ltd.	People’s Republic of China		100	%
BeiGene (Guangzhou) Innovation Technology Co., Ltd.	People’s Republic of China		100	%
BeiGene (Hong Kong) Co., Limited	Hong Kong		100	%
BeiGene Hopewell Urban Renewal, LLC	New Jersey, United States		100	%
BeiGene International GmbH	Switzerland		100	%
BeiGene Ireland Limited	Republic of Ireland		100	%
BeiGene (Italy) S.r.l.	Italy		100	%
BeiGene Japan, GK	Japan		100	%
BeiGene Korea Y.H.	South Korea		100	%
BeiGene Malaysia Sdn. Bhd.	Malaysia		100	%
BeiGene Mexico S. de R.L. de C.V.	Mexico		100	%
BeiGene Netherlands B.V.	Netherlands		100	%
BeiGene NZ Unlimited	New Zealand		100	%
BeiGene Peru (Sociedad Comercial de Responsabilidad Limitada – S.R.L)	Peru		100	%
BeiGene Pharmaceuticals GmbH	Switzerland		100	%
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd.	People’s Republic of China		100	%
BeiGene Pharmaceuticals Israel Ltd.	Israel		100	%
BeiGene Pharmaceutical (Shanghai) Co., Ltd.	People’s Republic of China		100	%
BeiGene Poland sp. z o.o.	Poland		100	%
BeiGene Portugal, Unipessoal Lda.	Portugal		100	%
BeiGene Shanghai	Cayman Islands		95	%
BeiGene Shanghai 101	Cayman Islands		95	%
BeiGene (Shanghai) Co., Ltd.	People’s Republic of China		100	%
BeiGene (Shanghai) Development Co., Ltd.	People’s Republic of China		95	%
BeiGene (Shanghai) Management Consulting Co., Ltd.	People’s Republic of China		100	%
BeiGene (Shanghai) Research & Development Co., Ltd.	People’s Republic of China		100	%
BeiGene Shanghai Asset Limited	Hong Kong		95	%
BeiGene Singapore Pte. Ltd.	Singapore		100	%
BeiGene South Africa Pty Ltd.	South Africa		100	%
BeiGene (Suzhou) Co., Ltd.	People’s Republic of China		100	%
BeiGene Sweden AB	Sweden		100	%
BeiGene Switzerland GmbH	Switzerland		100	%
BeiGene (Taiwan) Limited	Taiwan		100	%
BeiGene (Thailand) Ltd.	Thailand		100	%
BeiGene Turkey Medical Products Trade Limited Company	Turkey		100	%
BeiGene UK, Ltd.	United Kingdom		100	%
BeiGene United Kingdom, Ltd.	United Kingdom		100	%
BeiGene USA, Inc.	Delaware, United States		100	%
BeiGene US Holdings, LLC	Delaware, United States		100	%
BeiGene US Manufacturing Co., Inc.	Delaware, United States		100	%
Beijing Innerway Bio-tech Co., Ltd.	People’s Republic of China		100	%
Newco 101	Cayman Islands		100	%
SuGene Pharmaceuticals (Suzhou) Co., Ltd.	People’s Republic of China		100	%